In addition, discovery of a novel interaction partners including Kunitz-type protease inhibitor SPINT2, pointed to the novel mechanism of tumor suppressor role of COMT in ER dependent breast cancer through the interplay with MET signaling pathway. This evidence concerns the gene MET and breast carcinoma.